IA
KZR

IndexIQ Advisors’s Kezar Life Sciences KZR Stock Holding History

IndexIQ Advisors’s Portfolio KZR Stock Details KZR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,086
Closed -$1.19M – 1417
2021
Q4 		$1.19M Sell
7,086
-458
-6% -$51.7K 0.04% 273
2021
Q3 		$652K Buy
7,544
+756
+11% +$50K 0.02% 403
2021
Q2 		$369K Buy
6,788
+20
+0.3% +$1.14K 0.01% 858
2021
Q1 		$403K Buy
+6,768
New +$396K 0.01% 622

Other funds holding KZR

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

IndexIQ Advisors's KZR Position: Q1 2022 in Review

IndexIQ Advisors sold out of Kezar Life Sciences (KZR) in Q1 2022, closing a stake of 7,086 shares — an estimated $1.19M sold.

IndexIQ Advisors first reported a position in KZR in Q1 2021 and held it in 4 quarters. The position peaked at $1.19M in Q4 2021. 123 funds tracked by Wall St. Rank hold KZR as of Q1 2022.

  • IndexIQ Advisors reported no remaining Kezar Life Sciences position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 7,086 Kezar Life Sciences shares in Q1 2022, an estimated $1.19M.
  • IndexIQ Advisors first reported a position in Kezar Life Sciences in Q1 2021 and held it in 4 quarters.
  • IndexIQ Advisors's Kezar Life Sciences position peaked at $1.19M in Q4 2021.
  • 123 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.